Innate Lymphocytes and Innate-Like T Cells in Cancer

 Monday, May 9, 2022     10:15 AM – 12:15 PM ET     Oregon Ballroom 203

Innate Lymphocytes and Innate-Like T Cells in Cancer

Chairs

• Robert Welner, Univ. of Alabama at Birmingham
• Murad R. Mamedov, Univ. of California, San Francisco

Speakers

• Valeriya Kuznetsova, Univ. of Alabama at Birmingham, Perturbed function of natural killer cells by inflammatory cytokines in acute (AML) and chronic (CML) myeloid leukemias
• Sylvia M. Cruz, Univ. of California Davis Med. Ctr., Characterization of the tumor immune microenvironment in soft tissue sarcoma patients undergoing surgery
• Monica Cho,Univ. of Wisconsin-Madison, CD155 axis modulation promotes natural killer cell-mediated graft-versus-tumor effects against osteosarcoma
• Xia Liu, St. Louis Univ., The fate and function of NK cells in the suppressive tumor microenvironment
• Narendiran Rajasekaran, Northern Arizona Univ., Assembly and localization of extracellular matrix protein fibronectin modulates Natural killer cell infiltration in tumor spheroids
• Clemence Riffard, INSERM, LTi-like type 3 innate lymphoid cells are associated with the transient induction of tertiary lymphoid structures in inflamed pulmonary tissue
• Murad R. Mamedov, Univ. of California, San Francisco, Genome-wide CRISPR screens reveal metabolic and transcriptional regulation of BTN3A and cancer susceptibility to VγVδ2 T cell targeting